380 related articles for article (PubMed ID: 16884489)
1. Implication of calpain in neuronal apoptosis. A possible regulation of Alzheimer's disease.
Raynaud F; Marcilhac A
FEBS J; 2006 Aug; 273(15):3437-43. PubMed ID: 16884489
[TBL] [Abstract][Full Text] [Related]
2. [Intracellular signaling pathways, apoptosis and neurodegenerative diseases].
Marcilhac A
Psychol Neuropsychiatr Vieil; 2004 Sep; 2(3):203-14. PubMed ID: 15689335
[TBL] [Abstract][Full Text] [Related]
3. Tipping the apoptotic balance in Alzheimer's disease: the abortosis concept.
Raina AK; Zhu X; Shimohama S; Perry G; Smith MA
Cell Biochem Biophys; 2003; 39(3):249-55. PubMed ID: 14716079
[TBL] [Abstract][Full Text] [Related]
4. Caspase and calpain substrates: roles in synaptic plasticity and cell death.
Chan SL; Mattson MP
J Neurosci Res; 1999 Oct; 58(1):167-90. PubMed ID: 10491581
[TBL] [Abstract][Full Text] [Related]
5. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
6. Ca2+-dependent proteases in ischemic neuronal death: a conserved 'calpain-cathepsin cascade' from nematodes to primates.
Yamashima T
Cell Calcium; 2004; 36(3-4):285-93. PubMed ID: 15261484
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis in neurodegenerative disorders.
Mattson MP
Nat Rev Mol Cell Biol; 2000 Nov; 1(2):120-9. PubMed ID: 11253364
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial dysfunction in sporadic and genetic Alzheimer's disease.
Hauptmann S; Keil U; Scherping I; Bonert A; Eckert A; Müller WE
Exp Gerontol; 2006 Jul; 41(7):668-73. PubMed ID: 16677790
[TBL] [Abstract][Full Text] [Related]
9. Neuronal cell death in nervous system development, disease, and injury (Review).
Martin LJ
Int J Mol Med; 2001 May; 7(5):455-78. PubMed ID: 11295106
[TBL] [Abstract][Full Text] [Related]
10. Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets.
Pei JJ; Sjögren M; Winblad B
Curr Opin Psychiatry; 2008 Nov; 21(6):555-61. PubMed ID: 18852562
[TBL] [Abstract][Full Text] [Related]
11. No difference in expression of apoptosis-related proteins and apoptotic morphology in control, pathologically aged and Alzheimer's disease cases.
Woodhouse A; Dickson TC; West AK; McLean CA; Vickers JC
Neurobiol Dis; 2006 May; 22(2):323-33. PubMed ID: 16406795
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis in the nervous system.
Yuan J; Yankner BA
Nature; 2000 Oct; 407(6805):802-9. PubMed ID: 11048732
[TBL] [Abstract][Full Text] [Related]
13. Sp3 and sp4 transcription factor levels are increased in brains of patients with Alzheimer's disease.
Boutillier S; Lannes B; Buée L; Delacourte A; Rouaux C; Mohr M; Bellocq JP; Sellal F; Larmet Y; Boutillier AL; Loeffler JP
Neurodegener Dis; 2007; 4(6):413-23. PubMed ID: 17934324
[TBL] [Abstract][Full Text] [Related]
14. Conventional calpains and programmed cell death.
Łopatniuk P; Witkowski JM
Acta Biochim Pol; 2011; 58(3):287-96. PubMed ID: 21887410
[TBL] [Abstract][Full Text] [Related]
15. Amyloid beta peptide toxicity in differentiated PC12 cells: calpain-calpastatin, caspase, and membrane damage.
Vaisid T; Kosower NS; Elkind E; Barnoy S
J Neurosci Res; 2008 Aug; 86(10):2314-25. PubMed ID: 18438916
[TBL] [Abstract][Full Text] [Related]
16. Tauroursodeoxycholic acid modulates p53-mediated apoptosis in Alzheimer's disease mutant neuroblastoma cells.
Ramalho RM; Borralho PM; Castro RE; Solá S; Steer CJ; Rodrigues CM
J Neurochem; 2006 Sep; 98(5):1610-8. PubMed ID: 16923170
[TBL] [Abstract][Full Text] [Related]
17. [Preliminary results of the study of neuronal death and the expression of bcl-2 protein in Alzheimer's disease].
Erro E; Tuñón T
Rev Med Univ Navarra; 1997; 41(1):28-33. PubMed ID: 9580053
[TBL] [Abstract][Full Text] [Related]
18. S100-mediated signal transduction in the nervous system and neurological diseases.
Zimmer DB; Chaplin J; Baldwin A; Rast M
Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(2):201-14. PubMed ID: 16171556
[TBL] [Abstract][Full Text] [Related]
19. Complement component C1q inhibits beta-amyloid- and serum amyloid P-induced neurotoxicity via caspase- and calpain-independent mechanisms.
Pisalyaput K; Tenner AJ
J Neurochem; 2008 Feb; 104(3):696-707. PubMed ID: 17986223
[TBL] [Abstract][Full Text] [Related]
20. GSK-3 inhibitors for Alzheimer's disease.
Avila J; Hernández F
Expert Rev Neurother; 2007 Nov; 7(11):1527-33. PubMed ID: 17997701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
